Flamel Technologies (NASDAQ: FLML) announced that its once weekly formulation of exenatide, based on its Medusa drug delivery ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE